» Articles » PMID: 31540485

TWIST1 Heterodimerization with E12 Requires Coordinated Protein Phosphorylation to Regulate Periostin Expression

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2019 Sep 22
PMID 31540485
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Diffuse invasion into adjacent brain matter by glioblastoma (GBM) is largely responsible for their dismal prognosis. Previously, we showed that the TWIST1 (TW) bHLH transcription factor and its regulated gene periostin () promote invasive phenotypes of GBM cells. Since TW functional effects are regulated by phosphorylation and dimerization, we investigated how phosphorylation of serine 68 in TW regulates TW dimerization, expression, and invasion in glioma cells. Compared with wild-type TW, the hypophosphorylation mutant, TW(S68A), impaired TW heterodimerization with the E12 bHLH transcription factor and cell invasion in vitro but had no effect on TW homodimerization. Overexpression of TW:E12 forced dimerization constructs (FDCs) increased glioma cell invasion and upregulated pro-invasive proteins, including POSTN, in concert with cytoskeletal reorganization. By contrast, TW:TW homodimer FDCs inhibited POSTN expression and cell invasion in vitro. Further, phosphorylation of analogous PXSP phosphorylation sites in TW:E12 FDCs (TW S68 and E12 S139) coordinately regulated and mRNA expression. These results suggested that TW regulates pro-invasive phenotypes in part through coordinated phosphorylation events in TW and E12 that promote heterodimer formation and regulate downstream targets. This new mechanistic understanding provides potential therapeutic strategies to inhibit TW-POSTN signaling in GBM and other cancers.

Citing Articles

Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth.

Mikheeva S, Funk C, Horner P, Rostomily R, Mikheev A Mol Oncol. 2023; 18(3):517-527.

PMID: 37507199 PMC: 10920085. DOI: 10.1002/1878-0261.13496.


Cranium growth, patterning and homeostasis.

Ang P, Matrongolo M, Zietowski M, Nathan S, Reid R, Tischfield M Development. 2022; 149(22).

PMID: 36408946 PMC: 9793421. DOI: 10.1242/dev.201017.

References
1.
Jacqueroud L, Bouard C, Richard G, Payen L, Devouassoux-Shisheboran M, Spicer D . The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells. Neoplasia. 2016; 18(5):317-327. PMC: 4887617. DOI: 10.1016/j.neo.2016.03.007. View

2.
Goossens S, Vandamme N, Van Vlierberghe P, Berx G . EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017; 1868(2):584-591. DOI: 10.1016/j.bbcan.2017.06.006. View

3.
Gonzalez-Gonzalez L, Alonso J . Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression. Front Oncol. 2018; 8:225. PMC: 6005831. DOI: 10.3389/fonc.2018.00225. View

4.
Firulli A, Conway S . Phosphoregulation of Twist1 provides a mechanism of cell fate control. Curr Med Chem. 2008; 15(25):2641-7. PMC: 2744367. DOI: 10.2174/092986708785908987. View

5.
Vehlow A, Cordes N . Invasion as target for therapy of glioblastoma multiforme. Biochim Biophys Acta. 2013; 1836(2):236-44. DOI: 10.1016/j.bbcan.2013.07.001. View